Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hemogenyx Pharmaceuticals Share News (HEMO)
HEMO Share
Price
HEMO Share
News
HEMO Share
Chat
HEMO Share
Trades54
HEMO
Live RNS
HEMO Share
Charts
HEMO Level 2
Console
HEMO Live
Share Price
HEMO Broker
Ratings
HEMO Directors
Deals
HEMO Financial
Diary
HEMO
Fundamentals
HEMO Short
Positions
HEMO
Media
HEMO Company
Research
HEMO Company
Timeline
Hemogenyx Pharmaceuticals Information
Share Price Information for Hemogenyx Pharmaceuticals (HEMO)
Share Price is delayed by 15 minutes
Get Live Data
735.00
-34.00 (-4.36%)
Bid:
712.00
Ask:
779.00
Spread:
67.00 (9.41%)
Market Cap:
£49.98m
Last checked at -
Last checked at 
Intraday Hemogenyx Pharmaceuticals Share Chart
Hemogenyx Pharmaceuticals News
11 Feb 2020
Hemogenyx Gets US Patent For Postnatal Hemogenic Endothelial Cells
Hemogenyx Gets US Patent For Postnatal Hemogenic Endothelial Cells
30 Jan 2020
Hemogenyx Raises GBP648,200 To Continue T Cell Therapy Development
Hemogenyx Raises GBP648,200 To Continue T Cell Therapy Development
15 Jan 2020
Hemogenyx Shares Jump On Promising Data From Blood Cancer Therapy
Hemogenyx Shares Jump On Promising Data From Blood Cancer Therapy
18 Nov 2019
Hemogenyx CDX Antibody Treatment Potentially "Life-Saving"
Hemogenyx CDX Antibody Treatment Potentially "Life-Saving"
23 Oct 2019
Hemogenyx signs another deal with unnamed global pharma company
(Sharecast News) - Biopharmaceutical group Hemogenyx Pharmaceuticals announced on Wednesday that its wholly-owned subsidiary Immugenyx has entered int...
23 Oct 2019
Hemogenyx Inks USD75,000 Research Deal With Undisclosed Global Firm
Hemogenyx Inks USD75,000 Research Deal With Undisclosed Global Firm
30 Sep 2019
Hemogenyx Interim Loss Widens But CDX Antibody Work Progresses
Hemogenyx Interim Loss Widens But CDX Antibody Work Progresses
19 Oct 2018
Hemogenyx enters collaboration agreement with Orgenesis
(Sharecast News) - Biopharmaceutical group Hemogenyx has entered into a collaboration agreement with cell therapy outfit Orgenesis to further commerci...
Follow the stocks
